WASHINGTON — An advisory panel has urged the Food and Drug Administration to loosen its restrictions on the controversial diabetes drug Avandia, which was nearly wiped from the market in recent years after reports linking it to several heart-related complications.Read More »
A York County, Penn. jury has awarded $6 million to estate and family of a deceased Seven Valleys woman in a medical malpractice lawsuit against York Hospital and Cardiac Diagnostic Associates in York Township.Read More »
Much like 2009, 2010 was a busy year for prescription drug suits.
Tagged with: Accutane Allergan antidepressant Avandia AztraZeneca Botox Botox litigation Department of Justice DOJ epilepsy failure to warn GlaxoSmithKline heart attack hormone replacement therapy hormone replacement therapy litigation Johnson & Johnson Levaquin Neurontin Paxil Pfizer Premarin Prempro Provera Roche Seroquel WyethRead More »